Subtype

Malignant Exocrine Pancreas Neoplasm

360 active trials5 approved drugs27 evidence items

NCIt: C7430
DOID: 1795

Clinical trials

Registered studies

929 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 360
Recruiting: 210
Ph III recruiting: 23
Growth YoY: +39.4%
Industry share: 40%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (136)

No study matches these filters